menu
    • menu

    Company profile for Apellis Pharmaceuticals

    NEW Drugs in Dev: 3
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to...
    We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apellis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6400 Westwind Way, Suite A Crestwood, KY 40014
    Telephone
    Telephone
    (502) 241-4114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.apellis.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apellis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ApellisPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biogen Bets on $5.6 Billion buyout of Apellis
    Biogen Bets on $5.6 Billion buyout of Apellis

    01 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265288/0/en/Biogen-to-Acquire-Apellis-Enhancing-the-Company-s-Growth-Portfolio-in-Immunology-and-Rare-Disease-Bolstering-Growth-Outlook-and-Accelerating-Expansion-into-Nephrology.html

    GLOBENEWSWIRE
    01 Apr 2026
    Share Share
    Apellis Appoints Mikael Dolsten, M.D., Ph.D., To Board
    Apellis Appoints Mikael Dolsten, M.D., Ph.D., To Board

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247221/0/en/Apellis-Announces-Mikael-Dolsten-M-D-Ph-D-to-Join-Board-of-Directors.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Apellis Pharma Reveals 2025 Financial Result Performance
    Apellis Pharma Reveals 2025 Financial Result Performance

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243396/0/en/Apellis-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Apellis Pharma To Present At TD Cowen Health Care Conference
    Apellis Pharma To Present At TD Cowen Health Care Conference

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242458/0/en/Apellis-Pharmaceuticals-to-Present-at-the-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Apellis to Deliver Eight Oral Talks at Macula Society Meeting
    Apellis to Deliver Eight Oral Talks at Macula Society Meeting

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240946/0/en/Apellis-Announces-Eight-Oral-Presentations-at-the-49th-Macula-Society-Annual-Meeting.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Apellis Pharma To Discuss 2025 Financial Results In Feb 24 Call
    Apellis Pharma To Discuss 2025 Financial Results In Feb 24 Call

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235166/0/en/Apellis-Pharmaceuticals-to-Host-Conference-Call-on-February-24-2026-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search